Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC
MET 外显子 14 突变型 NSCLC 患者对 MET 酪氨酸激酶抑制剂获得性耐药的分子机制
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-19-3608
Gonzalo Recondo, Magda Bahcall, Liam F Spurr, Jianwei Che, Biagio Ricciuti, Giulia C Leonardi, Ying-Chun Lo, Yvonne Y Li, Giuseppe Lamberti, Tom Nguyen, Marina S D Milan, Deepti Venkatraman, Renato Umeton, Cloud P Paweletz, Adem Albayrak, Andrew D Cherniack, Kristin S Price, Stephen R Fairclough, Mi
